WallStreetZenWallStreetZen

NASDAQ: PSTX
Poseida Therapeutics Inc Stock Ownership - Who owns Poseida Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Poseida Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark J. GergenExecutive Chairman2024-03-0134,157$4.13
$141.07kSell
Harry J. LeonhardtGC Chief Compliance Officer2024-03-0116,306$4.13
$67.34kSell
Johanna MyletChief Financial Officer2024-03-0118,091$4.13
$74.72kSell
Brent WarnerPresident Gene Therapy2024-03-0135,739$4.13
$147.60kSell
Mark J. GergenExecutive Chairman2024-02-0147,162$3.41
$160.82kSell

1 of 1

PSTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PSTX insiders and whales buy or sell their stock.

PSTX Shareholders

What type of owners hold Poseida Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.87%14,343,665$29.26MInstitution
Malin Life Sciences Holdings Ltd12.27%11,835,673$24.14MInsider
Sean Murphy9.53%9,198,125$18.76MInsider
Pentwater Capital Management LP6.19%5,975,000$12.19MInstitution
Pharma Ag Novartis6.12%5,908,089$12.05MInsider
Blackrock Inc5.21%5,031,173$10.26MInstitution
Luke Corning5.19%5,006,527$10.21MInsider
Silverarc Capital Management LLC3.84%3,705,779$7.56MInstitution
Vanguard Group Inc3.00%2,899,319$5.91MInstitution
David Hirsch2.81%2,714,245$5.54MInsider

1 of 3

PSTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PSTX46.85%40.59%Net SellingNet Selling
IPSC27.27%59.24%Net SellingNet Selling
NBTX26.32%0.00%
ELEV53.13%24.22%Net SellingNet Selling
CRDF11.85%34.59%Net Buying
View Top Biotech Stocks

Poseida Therapeutics Stock Ownership FAQ

Who owns Poseida Therapeutics?

Poseida Therapeutics (NASDAQ: PSTX) is owned by 46.85% institutional shareholders, 40.59% Poseida Therapeutics insiders, and 12.56% retail investors. Malin Life Sciences Holdings Ltd is the largest individual Poseida Therapeutics shareholder, owning 11.84M shares representing 12.27% of the company. Malin Life Sciences Holdings Ltd's Poseida Therapeutics shares are currently valued at $23.67M.

If you're new to stock investing, here's how to buy Poseida Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.